EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C9H13NO2 |
| Net Charge | 0 |
| Average Mass | 167.208 |
| Monoisotopic Mass | 167.09463 |
| SMILES | CNC[C@H](O)c1cccc(O)c1 |
| InChI | InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1 |
| InChIKey | SONNWYBIRXJNDC-VIFPVBQESA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | alpha-adrenergic agonist An agent that selectively binds to and activates α-adrenergic receptors. anti-obesity agent Any substance which is used to reduce or control weight. sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. protective agent Synthetic or natural substance which is given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. alpha-adrenergic agonist An agent that selectively binds to and activates α-adrenergic receptors. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. vasoconstrictor agent Drug used to cause constriction of the blood vessels. anti-inflammatory agent Any compound that has anti-inflammatory effects. cardiotonic drug A drug that has a strengthening effect on the heart or that can increase cardiac output. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. nasal decongestant A drug used to relieve nasal congestion in the upper respiratory tract. mydriatic agent Agent that dilates the pupil. Used in eye diseases and to facilitate eye examination. It may be either a sympathomimetic or parasympatholytic. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| phenylephrine (CHEBI:8093) has role analgesic (CHEBI:35480) |
| phenylephrine (CHEBI:8093) has role anti-inflammatory agent (CHEBI:67079) |
| phenylephrine (CHEBI:8093) has role anti-obesity agent (CHEBI:74518) |
| phenylephrine (CHEBI:8093) has role antidepressant (CHEBI:35469) |
| phenylephrine (CHEBI:8093) has role antihypertensive agent (CHEBI:35674) |
| phenylephrine (CHEBI:8093) has role antiinfective agent (CHEBI:35441) |
| phenylephrine (CHEBI:8093) has role antineoplastic agent (CHEBI:35610) |
| phenylephrine (CHEBI:8093) has role antiviral agent (CHEBI:22587) |
| phenylephrine (CHEBI:8093) has role cardiotonic drug (CHEBI:38147) |
| phenylephrine (CHEBI:8093) has role cardiovascular drug (CHEBI:35554) |
| phenylephrine (CHEBI:8093) has role mydriatic agent (CHEBI:50513) |
| phenylephrine (CHEBI:8093) has role nasal decongestant (CHEBI:77715) |
| phenylephrine (CHEBI:8093) has role ophthalmology drug (CHEBI:66981) |
| phenylephrine (CHEBI:8093) has role protective agent (CHEBI:50267) |
| phenylephrine (CHEBI:8093) has role sympathomimetic agent (CHEBI:35524) |
| phenylephrine (CHEBI:8093) has role vasoconstrictor agent (CHEBI:50514) |
| phenylephrine (CHEBI:8093) has role α-adrenergic agonist (CHEBI:35569) |
| phenylephrine (CHEBI:8093) is a phenols (CHEBI:33853) |
| phenylephrine (CHEBI:8093) is a phenylethanolamines (CHEBI:25990) |
| phenylephrine (CHEBI:8093) is a secondary amino compound (CHEBI:50995) |
| phenylephrine (CHEBI:8093) is conjugate base of phenylephrine(1+) (CHEBI:132294) |
| Incoming Relation(s) |
| phenylephrine(1+) (CHEBI:132294) is conjugate acid of phenylephrine (CHEBI:8093) |
| IUPAC Name |
|---|
| 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol |
| INNs | Source |
|---|---|
| fenilefrina | ChemIDplus |
| phenylephrine | ChemIDplus |
| phenylephrinum | ChemIDplus |
| Synonyms | Source |
|---|---|
| AB-101 (PHENYLEPHRINE) | ChEMBL |
| Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)- | NIST Chemistry WebBook |
| Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- | ChemIDplus |
| Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)- | ChemIDplus |
| Cyclomydril | ChEMBL |
| Duo-medihaler | ChEMBL |
| Citations |
|---|